Skip to content

Boston Scientific

US · BSX #364 by market cap Listed 1970
41.98 -1.01 -2.35%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
9
■ Upgrades■ Downgrades
  • 0 upgrades vs 9 downgrades among tracked analyst rating changes.
  • Most recent: Oppenheimer moved from Buy to Hold on 2026-10-29.

Analyst consensus 22 analysts

Buy
Avg price target 50.05 +19.2%
Price target rangecurrent 41.98
Low44.00
Avg50.05
High60.00
Buy 64% Hold 36% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-19 Citi -- Hold 44.00
2026-11-18 Citi -- Hold 44.00
2026-11-03 CCORF -- Buy 48.00
2026-11-02 Argus Research -- Hold --
2026-11-02 J.P. Morgan -- Hold --
2026-11-01 Citi -- Hold 44.00
2026-10-30 TD Cowen -- Hold 46.00
2026-10-30 BofA Securities -- Buy 54.00
2026-10-30 Barclays -- Hold 45.00
2026-10-29 TD Cowen -- Hold 46.00
2026-10-29 CCORF -- Buy 48.00
2026-10-29 Bernstein -- Buy 49.00
2026-10-29 UBS -- Buy 57.00
2026-10-29 Mizuho Securities -- Buy 50.00
2026-10-29 Baird -- Buy 51.00
2026-10-29 Deutsche Bank -- Buy 48.00
2026-10-29 Citi -- Hold 44.00
2026-10-29 Leerink Partners -- Buy 50.00
2026-10-29 Barclays -- Hold 48.00
2026-10-29 Oppenheimer -- Hold --
2026-10-28 BTIG -- Buy 49.00
2026-10-28 Jefferies -- Hold 46.00
2026-10-28 Needham -- Buy 48.00
2026-10-28 RBC Capital -- Buy 52.00
2026-10-28 J.P. Morgan -- Hold 46.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-29 Oppenheimer Buy → Hold --
2026-10-29 TD Cowen Buy → Hold 46.00
2026-10-28 Jefferies Buy → Hold 46.00
2026-10-28 J.P. Morgan Buy → Hold 46.00
2026-10-07 Barclays Buy → Hold 48.00
2026-09-17 Citi Buy → Hold 50.00
2026-07-30 Argus Research Buy → Hold --
2026-05-29 Wolfe Research Buy → Hold --
2026-05-28 Wells Fargo Buy → Hold 55.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-28 -- ±7.57% -5.84% (in line)
2026/Q2 2026-07-29 -- ±7.84% -0.04% (in line)
2026/Q1 2026-04-22 -- ±5.97% +8.99% (beat)
2025/Q4 2026-02-04 -- ±4.71% -17.59% (beat)
2025/Q3 2025-10-22 -- ±3.92% +3.95% (beat)
2025/Q2 2025-07-23 -- ±5.03% +4.46% (in line)
2025/Q1 2025-04-23 -- ±6.17% +4.07% (in line)
2024/Q4 2025-02-05 -- ±4.53% +1.38% (in line)
2024/Q3 2024-10-23 -- ±6.37% -0.64% (in line)
2024/Q2 2024-07-24 -- -- -1.06%
2024/Q1 2024-04-24 -- ±5.79% +5.68% (in line)
2023/Q3 2023-10-26 -- ±4.07% -0.42% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.

Boston Scientific discussion 0 comments

Add a comment